VistaGen Therapeutics, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: South San Francisco CA United States (1998)

Organization Overview

First Clinical Trial
2011
NCT01483846
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

VistaGen Therapeutics | VistaGen Therapeutics, Inc.